Drug Therapy, Combination
"Drug Therapy, Combination" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Therapy with two or more separate preparations given for a combined effect.
| Descriptor ID |
D004359
|
| MeSH Number(s) |
E02.319.310
|
| Concept/Terms |
Drug Therapy, Combination- Drug Therapy, Combination
- Combination Chemotherapy
- Drug Polytherapy
- Drug Polytherapies
- Polytherapies, Drug
- Polytherapy, Drug
- Therapy, Combination Drug
- Chemotherapy, Combination
- Chemotherapies, Combination
- Combination Chemotherapies
- Combination Drug Therapy
- Combination Drug Therapies
- Drug Therapies, Combination
- Therapies, Combination Drug
|
Below are MeSH descriptors whose meaning is more general than "Drug Therapy, Combination".
Below are MeSH descriptors whose meaning is more specific than "Drug Therapy, Combination".
This graph shows the total number of publications written about "Drug Therapy, Combination" by people in this website by year, and whether "Drug Therapy, Combination" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 18 | 18 |
| 1997 | 1 | 18 | 19 |
| 1998 | 2 | 13 | 15 |
| 1999 | 1 | 12 | 13 |
| 2000 | 1 | 12 | 13 |
| 2001 | 0 | 12 | 12 |
| 2002 | 1 | 18 | 19 |
| 2003 | 4 | 37 | 41 |
| 2004 | 3 | 30 | 33 |
| 2005 | 0 | 23 | 23 |
| 2006 | 0 | 25 | 25 |
| 2007 | 0 | 25 | 25 |
| 2008 | 0 | 32 | 32 |
| 2009 | 0 | 41 | 41 |
| 2010 | 0 | 28 | 28 |
| 2011 | 2 | 41 | 43 |
| 2012 | 1 | 36 | 37 |
| 2013 | 1 | 31 | 32 |
| 2014 | 0 | 36 | 36 |
| 2015 | 1 | 34 | 35 |
| 2016 | 0 | 32 | 32 |
| 2017 | 0 | 36 | 36 |
| 2018 | 4 | 41 | 45 |
| 2019 | 1 | 34 | 35 |
| 2020 | 1 | 38 | 39 |
| 2021 | 0 | 17 | 17 |
| 2022 | 1 | 10 | 11 |
| 2023 | 1 | 16 | 17 |
| 2024 | 3 | 17 | 20 |
| 2025 | 0 | 19 | 19 |
| 2026 | 0 | 16 | 16 |
To return to the timeline,
click here.
Below are the most recent publications written about "Drug Therapy, Combination" by people in Profiles.
-
Losartan and prednisolone for post-COVID syndrome and cardiac inflammation: a randomized, double-blind, placebo-controlled trial. Nat Commun. 2026 07 30; 17(1).
-
Combination cardiometabolic therapy in type 2 diabetes: optimizing SGLT2 inhibitor and GLP-1 receptor agonist use. Curr Atheroscler Rep. 2026 Jul 18; 28(1).
-
High Potency Proton Pump Inhibitor Versus Vonoprazan in Helicobacter pylori Triple Therapy. Helicobacter. 2026 Jul-Aug; 31(4):e70152.
-
Evaluating time to treatment intensification among drug na?ve type 2 diabetes patients: a comparison of initial combination therapy vs step-therapy approaches. Curr Med Res Opin. 2026 Apr; 42(4):699-711.
-
Safety and Synergy of Finerenone and Empagliflozin in Lowering Blood Pressure. Hypertension. 2026 Sep; 83(9):e27036.
-
Effect of the initial combination approach vs initial monotherapy approach on 1-year trajectories of adherence in drug-naive patients with type 2 diabetes. J Manag Care Spec Pharm. 2026 Jun; 32(6):717-734.
-
Triple oral therapy combining metformin, SGLT-2 and DPP-4 inhibitors versus dual therapy in type 2 diabetes mellitus: A systematic review and meta-analysis. Medicine (Baltimore). 2026 May 29; 105(22):e49050.
-
Association of Inhaled Corticosteroid and Long-Acting Beta Agonist Combination Versus Inhaled Corticosteroid Only Inhalers on Adherence and Asthma Outcomes. Pediatr Pulmonol. 2026 May; 61(5):e71673.
-
Mitragynine and naltrexone alone and in combination reduce alcohol self-administration in female Sprague Dawley rats. Drug Alcohol Depend. 2026 Jun 01; 283:113126.
-
Intracoronary Imaging and Transcriptomic Characteristics Before and After Maximum Lipid-Lowering Therapy: YELLOW-III Study of Evolocumab and Maximum Statin Therapy in Chronic Coronary Disease. JACC Cardiovasc Imaging. 2026 Apr; 19(4):516-534.